GlassScriptPhysician profile
Khalid B Ahmed
NPI 1134193923
$1,535.48
in general payments reported to CMS, 2019-2025
14 companies · $341 in 2025
The $341 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $33.53 · 2021: $238 · 2022: $52.58 · 2023: $577 · 2024: $293 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zynex Medical, INC. | $705.65 | 2023-2025 | Nexwave |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $286.42 | 2021-2025 | Relistor |
| Pfizer INC. | $99.05 | 2020-2024 | |
| Vertex Pharmaceuticals Incorporated | $79.55 | 2024 | |
| Redhill Biopharma INC. | $70.50 | 2021 | |
| Lilly USA, LLC | $57.11 | 2023-2024 | Mounjaro, Zepbound |
| Lucid Diagnostics INC. | $51.69 | 2023 | |
| Grt US Holding, INC. | $45.00 | 2021 | |
| Emergent Biosolutions INC. | $45.00 | 2021 | |
| Averitas Pharma INC. | $24.50 | 2024 | Qutenza |
| Vision Quest Industries INC. | $20.19 | 2024 | Oactive Align Custom R |
| Baudax Bio INC. | $18.69 | 2021 | |
| Fidia Pharma USA INC. | $16.10 | 2023 | Triluron, Hymovis |
| Sanofi-Aventis U.S. LLC | $16.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.